Sadia Choudhury Shimmi and M. Tanveer Hossain Parash (2021) Children vaccination of COVID-19. Borneo Journal of Medical Sciences, 15. pp. 1-3. ISSN 1985-1758 (P-ISSN) , 2710-7353 (E-ISSN)
![[img]](https://eprints.ums.edu.my/style/images/fileicons/text.png) |
Text
Children vaccination of COVID-19_ABSTRACT.pdf Download (60kB) |
|
Text
Children vaccination of COVID-19.pdf Restricted to Registered users only Download (160kB) | Request a copy |
Abstract
The Delta variant is currently the highly contagious predominant variant of the SARS-CoV-2 virus worldwide that causes severe illness more than the previous variants in unvaccinated people (CDC, 2021). At a White House briefing, the National Institute of Allergy and Infectious Diseases director, Anthony Fauci, predicted that there would be an increase in the number of child hospitalisation proportionate to the increased number of children getting infected with the Delta variant (Press briefing White House, 2021). In response to this situation, the FDA (U.S. Food and Drug Administration) approved Pfizer-BioNTech and Moderna vaccines for children aged 12 – 17 years. Vaccines in children aged 5 – 11 years are currently under clinical trial (Sick-Samuels & Messina, 2021).
| Item Type: | Article |
|---|---|
| Keyword: | Children , Vaccination , Covid-19 |
| Subjects: | Q Science > QR Microbiology > QR1-502 Microbiology > QR180-189.5 Immunology |
| Department: | FACULTY > Faculty of Medicine and Health Sciences |
| Depositing User: | SAFRUDIN BIN DARUN - |
| Date Deposited: | 23 Mar 2022 09:26 |
| Last Modified: | 23 Mar 2022 09:26 |
| URI: | https://eprints.ums.edu.my/id/eprint/31993 |
Actions (login required)
 |
View Item |